InvestorsHub Logo
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Re: None

Friday, 02/17/2017 7:33:49 PM

Friday, February 17, 2017 7:33:49 PM

Post# of 1752
Exelixis Announces Phase 1 Trial Results for Cabozantinib in Combination with Nivolumab with or without Ipilimumab in Refractory Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

http://finance.yahoo.com/news/exelixis-announces-phase-1-trial-220200818.html

GWPH ZYNE CARA OWCP NMUS IMLFF PMCB

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EXEL News